Vemlidy (tenofovir alafenamide)

Manufacturer:
Gilead
Route of Administration: 
Oral
Site of Care:
Outpatient
Website: 
  • Manufacturer Website
phone: 
1-855-769-7284

Approved Indication:

treatment of chronic hepatitis B virus infection in adults and pediatric patients 6 years of age and older and weighing at least 25 kg with compensated liver disease

Conditions:

  • Chronic Viral Hepatitis B

Therapeutic Area:

  • Gastroenterology
  • Hepatology
  • Infectious Disease